Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II
Steven J. Forrester(Emory University), Victor Rizzo(University of Iowa), Takashi Obama(Showa Pharmaceutical University), Tatsuo Kawai(University of Iowa), Kyle Preston(Temple University), Zhen Yan(Shenyang Ligong University), Michael Boyer(Chris O’Brien Lifehouse), Katherine J. Elliott(Cornell University), Satoru Eguchi(University of South Florida)
Cited by 59
Related Papers
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
|Circulation Research|2018|2k